These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25449695)

  • 1. Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction.
    Mouton J; Loos B; Moolman-Smook JC; Kinnear CJ
    Exp Cell Res; 2015 Feb; 331(2):338-51. PubMed ID: 25449695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients.
    Mouton JM; van der Merwe L; Goosen A; Revera M; Brink PA; Moolman-Smook JC; Kinnear C
    Hum Genet; 2016 May; 135(5):477-483. PubMed ID: 26969327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C.
    Uys GM; Ramburan A; Loos B; Kinnear CJ; Korkie LJ; Mouton J; Riedemann J; Moolman-Smook JC
    BMC Cell Biol; 2011 May; 12():18. PubMed ID: 21569246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
    J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations.
    Moolman-Smook J; Flashman E; de Lange W; Li Z; Corfield V; Redwood C; Watkins H
    Circ Res; 2002 Oct; 91(8):704-11. PubMed ID: 12386147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy mutations in
    Toepfer CN; Wakimoto H; Garfinkel AC; McDonough B; Liao D; Jiang J; Tai AC; Gorham JM; Lunde IG; Lun M; Lynch TL; McNamara JW; Sadayappan S; Redwood CS; Watkins HC; Seidman JG; Seidman CE
    Sci Transl Med; 2019 Jan; 11(476):. PubMed ID: 30674652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.
    Pohlmann L; Kröger I; Vignier N; Schlossarek S; Krämer E; Coirault C; Sultan KR; El-Armouche A; Winegrad S; Eschenhagen T; Carrier L
    Circ Res; 2007 Oct; 101(9):928-38. PubMed ID: 17823372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HCM-causing Y235S cMyBPC mutation accelerates contractile function by altering C1 domain structure.
    Doh CY; Li J; Mamidi R; Stelzer JE
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):661-677. PubMed ID: 30611859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
    Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
    Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
    Witjas-Paalberends ER; Piroddi N; Stam K; van Dijk SJ; Oliviera VS; Ferrara C; Scellini B; Hazebroek M; ten Cate FJ; van Slegtenhorst M; dos Remedios C; Niessen HW; Tesi C; Stienen GJ; Heymans S; Michels M; Poggesi C; van der Velden J
    Cardiovasc Res; 2013 Aug; 99(3):432-41. PubMed ID: 23674513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction.
    Bahrudin U; Morikawa K; Takeuchi A; Kurata Y; Miake J; Mizuta E; Adachi K; Higaki K; Yamamoto Y; Shirayoshi Y; Yoshida A; Kato M; Yamamoto K; Nanba E; Morisaki H; Morisaki T; Matsuoka S; Ninomiya H; Hisatome I
    J Mol Biol; 2011 Nov; 413(4):857-78. PubMed ID: 21939669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin binding protein-C: enigmatic regulator of cardiac contraction.
    Oakley CE; Chamoun J; Brown LJ; Hambly BD
    Int J Biochem Cell Biol; 2007; 39(12):2161-6. PubMed ID: 17320463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility.
    Hosono Y; Usukura J; Yamaguchi T; Yanagisawa K; Suzuki M; Takahashi T
    Biochem Biophys Res Commun; 2012 Nov; 428(1):173-8. PubMed ID: 23068101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations.
    Cohn R; Thakar K; Lowe A; Ladha FA; Pettinato AM; Romano R; Meredith E; Chen YS; Atamanuk K; Huey BD; Hinson JT
    Stem Cell Reports; 2019 Jan; 12(1):71-83. PubMed ID: 30554920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SarcTrack.
    Toepfer CN; Sharma A; Cicconet M; Garfinkel AC; Mücke M; Neyazi M; Willcox JAL; Agarwal R; Schmid M; Rao J; Ewoldt J; Pourquié O; Chopra A; Chen CS; Seidman JG; Seidman CE
    Circ Res; 2019 Apr; 124(8):1172-1183. PubMed ID: 30700234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contractility-dependent actin dynamics in cardiomyocyte sarcomeres.
    Skwarek-Maruszewska A; Hotulainen P; Mattila PK; Lappalainen P
    J Cell Sci; 2009 Jun; 122(Pt 12):2119-26. PubMed ID: 19470580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes.
    Herron TJ; Vandenboom R; Fomicheva E; Mundada L; Edwards T; Metzger JM
    Circ Res; 2007 Apr; 100(8):1182-90. PubMed ID: 17363698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.
    McNamara JW; Li A; Lal S; Bos JM; Harris SP; van der Velden J; Ackerman MJ; Cooke R; Dos Remedios CG
    PLoS One; 2017; 12(6):e0180064. PubMed ID: 28658286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-box and leucine-rich repeat protein 22 is a cardiac-enriched F-box protein that regulates sarcomeric protein turnover and is essential for maintenance of contractile function in vivo.
    Spaich S; Will RD; Just S; Spaich S; Kuhn C; Frank D; Berger IM; Wiemann S; Korn B; Koegl M; Backs J; Katus HA; Rottbauer W; Frey N
    Circ Res; 2012 Dec; 111(12):1504-16. PubMed ID: 22972877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.